Last reviewed · How we verify
NCT06955351: RESPOND
REsuscitation Survey of Police Officers in New Taipei City for Duty
trial testing Survey by Questionnaire in Bystander in 4,867 participants. Completed in 2 April 2025.
1 April 2025
Quick facts
| Lead sponsor | Far Eastern Memorial Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,867 |
| Start date | 1 December 2023 |
| Primary completion | 1 April 2025 |
| Estimated completion | 2 April 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Survey by Questionnaire
Conditions studied
- Bystander — all drugs for Bystander →
- Chest Compression — all drugs for Chest Compression →
- Out of Hospital Cardiac Arrest — all drugs for Out of Hospital Cardiac Arrest →
- AED — all drugs for AED →
Sponsor
Far Eastern Memorial Hospital
Who can join
Eligibility, any sex, with Bystander or Chest Compression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Out-of-hospital cardiac arrest (OHCA) remains a time-critical emergency where early cardiopulmonary resuscitation (CPR) and timely defibrillation using an automated external defibrillator (AED) are key to improving survival and neurological outcomes. Although Taipei has implemented dispatch-assisted CPR, delays remain between arrest recognition and AED application due to manpower and policy limitations. International guidelines, including the Global Resuscitation Alliance's ten steps to improve OHCA outcomes, recommend involving police as first responders. Prior studies from the United States and Switzerland demonstrate that police often arrive before emergency medical services (EMS), underscoring their potential role in reducing response times. However, police have not been officially included in OHCA dispatch systems in any region of Taiwan. This study aims to evaluate the willingness of police officers in New Taipei City to participate in prehospital resuscitation through a structured questionnaire. The survey also explores perceived facilitators and barriers to involvement. Findings will inform future training programs and strategies to promote police integration into prehospital emergency response systems, with the ultimate goal of improving OHCA survival rates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06955351
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Far Eastern Memorial Hospital trials
Trials by the same sponsor.
- NCT07385976 — The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients · not yet recruiting
- NCT07107542 — Exploring the Relationship Between Mini-Clinical Evaluation Exercise (Mini-CEX) and Entrustable Professional Activities · not yet recruiting
- NCT07114653 — The Role of POLE Mutation in High Risk Endometrial Cancer. · recruiting
- NCT07105345 — Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD · NA · recruiting
- NCT07110350 — Clinical Outcomes of Non-Indicated Staged Laparotomies in Abdominal Trauma · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06955351 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Far Eastern Memorial Hospital
- Last refreshed: 2 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06955351.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing